Walk in or schedule your Pfizer COVID-19 vaccine! Monday through Thursday: 8 a.m. - 5 p.m. and Friday: 8 a.m. - noon >

Showing 1 - 1 of 1 Prostate Cancers
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Status: Enrolling

Investigator: Jorge Darcourt

Study Coordinator:

Phone:

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. ... Read more >